Acne Vulgaris Therapy
Data from E. Bagatin et al provide new insights into acne vulgaris therapy
Published in Hospital Law Weekly, May 6th, 2010
"Dermabrasion for atrophic acne scar revision is not recommended 6 to 12 months from the end of oral isotretinoin treatment. To evaluate wound healing after localized dermabrasion in patients receiving oral isotretinoin. Interventional, prospective study involving seven patients taking oral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2010-05-06)
More Articles from Hospital Law Weekly
- Abdominal Aortic Aneurysm Risk Factors
Research reports on abdominal aortic aneurysm risk factors from Cedars-Sinai Medical Center, Department of Surgery provide new insights - Amerigroup Foundation
Amerigroup Foundation Honors Texas Rep. John Zerwas as a 'Champion for Children' - Children's Hospital Los Angeles
Hand Held Imaging Device Provides Important Evidence in Diagnosis of Shaken Baby Syndrome - Harvard School of Public Health
Gay men and lesbians more likely to experience violent events and subsequent PTSD - Identity Force
Delayed Compliance with New Regulations Has Increased Data Breaches and Medical Identity Theft in U.S. Hospitals - Life Sciences
Research by J. Smetzer and colleagues in life sciences provides new insights - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
